Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
MS Patient, Ph.D.: When Old Symptoms Resurface
Depletion of B cells by a humanized anti-CD20 antibody PRO70769 in Macaca fascicularis.
Making Treatment & Lifestyle Decisions: Thinking About Benefits & Risks
Health literacy and patient safety: help patients understand
Relapse frequency in transitioning from natalizumab to dimethyl fumarate: assessment of risk factors.
American Society for Neurochemistry 2014
Asymptomatic subjects differ less from their twin siblings with MS than from healthy controls in cognitive functioning. A Finnish Twin Cohort study.
Experimental models of multiple sclerosis.
Randomized phase I trials of the safety/tolerability of anti-LINGO-1 monoclonal antibody BIIB033
A Study of Ocrelizumab in Comparison with Interferon Beta 1a (Rebif) in Patients with Relapsing Multiple Sclerosis
Few MS Patients Fail to Receive Disease-Modifying Therapy
Core Value of Amyloids
Comparison of brainstem reflex recordings and evoked potentials with clinical and MRI data to assess brainstem dysfunction in multiple sclerosis: a short-term follow-up.
Consent guidance: patients and doctors making decisions together
ACTRIMS Forum 2016
Neuromyelitis optica: not a multiple sclerosis variant.
A Study of Ocrelizumab in Patients with Primary Progressive Multiple Sclerosis
A Study of Ocrelizumab in Comparison with Interferon Beta 1a (Rebif) in Patients with Relapsing Multiple Sclerosis
Body temperature is elevated and linked to fatigue in relapsing-remitting multiple sclerosis, even without heat exposure.
11th International Congress of Neuroimmunology Conference
MS Research Roundup: February 7, 2014
Relationships between quantitative spinal cord MRI and retinal layers in multiple sclerosis.
MS Patient, Ph.D.: Patience, the Rusty Adjective
Dietary patterns not associated with the risk of multiple sclerosis
Harry Lee Parker and paroxysmal dysarthria and ataxia.
Pages
« first
‹ previous
…
37
38
39
40
41
42
43
44
45
…
next ›
last »
